CliffBio
small molecule

BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

BRIMONIDINE TARTRATE; TIMOLOL MALEATE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameBRIMONIDINE TARTRATE AND TIMOLOL MALEATE
Active ingredientBRIMONIDINE TARTRATE; TIMOLOL MALEATE
Strength0.2%;EQ 0.5% BASE
Dosage formSOLUTION/DROPS
RouteOPHTHALMIC
ModalitySmall molecule
FDA approvalApril 2022
Marketing statusRX

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.